Copyright
©The Author(s) 2015.
World J Gastroenterol. Nov 28, 2015; 21(44): 12558-12575
Published online Nov 28, 2015. doi: 10.3748/wjg.v21.i44.12558
Published online Nov 28, 2015. doi: 10.3748/wjg.v21.i44.12558
Table 2 A Lists of hepatitis B virus vaccines in development
| Name of vaccine | Type | Developed by | Phase |
| Sci-B-Vac | Prophylactic 3rd generation vaccine | SciVac Ltd, Israel | Approved in Israel, Asia and Africa |
| HEPLISAV-B | Prophylactic vaccine | Dynvax Technologies Corporation, United States | Phase III |
| GS-4774 | Therapeutic vaccine | Gilead Sciences, United States | Phase II |
| Hepsyn-B | Therapeutic vaccine | Immune Targeting Systems Ltd, United Kingdom | Pre-clinical |
| VAXINE’s HBV Vaccine | Therapeutic | Vaxine Pty, Ltd, Australia | Phase I |
| VAXINE’s HBV Vaccine | Prophylactic | Vaxine Pty, Ltd, Australia | Phase II |
| HBV+ DRibbles vaccine | Prophylactic and therapeutic | Southeast University, Nanjing, Jiangsu, China | Pre-clinical |
| ABX 203 | Therapeutic | ABIVAX, France | Multicenter Phase II/III Trials |
| INO-1800 | Therapeuti | Inovio Pharmaceuticals, United States and Roche | Phase I (expected to start in 2015) |
| DV-601 | Therapeutic | Dynvax Technologies Corporation, United States | Phase Ib |
| Altravax Therapeutic Vaccine | Therapeutic | Altravax, Inc, United States | Pre-Clinical |
- Citation: Manzoor S, Saalim M, Imran M, Resham S, Ashraf J. Hepatitis B virus therapy: What’s the future holding for us? World J Gastroenterol 2015; 21(44): 12558-12575
- URL: https://www.wjgnet.com/1007-9327/full/v21/i44/12558.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i44.12558